MRK-016
MRK-016
MRK-016 (/ˈɑːrkeɪ ˈziəroʊ ˈsɪksˈtiːn/), is a pharmaceutical drug developed by Merck & Co., primarily used in the field of neuroscience and psychopharmacology.
Etymology
The name "MRK-016" is derived from the initials of the company that developed it, Merck & Co., followed by a unique identifying number. The use of such alphanumeric codes is common in the pharmaceutical industry for the identification of drugs during their development phase.
Usage
MRK-016 is a GABA-A receptor negative allosteric modulator. It is used in research settings to study the role of the GABA-A receptor in various neurological and psychiatric conditions.
Related Terms
- GABA-A receptor: A type of protein which MRK-016 interacts with, playing a crucial role in the functioning of the nervous system.
- Negative allosteric modulator: A type of drug that decreases the activity of a receptor protein by binding to a site different from the active site.
- Neuroscience: The scientific study of the nervous system, a field in which MRK-016 is often used.
- Psychopharmacology: The study of the effects of drugs on the mind and behavior, another field where MRK-016 is commonly used.
- Merck & Co.: The pharmaceutical company that developed MRK-016.
External links
- Medical encyclopedia article on MRK-016
- Wikipedia's article - MRK-016
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski